Showing results (571-580 of 633) with videos related to
Sort By:
Pageof 64
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1983
Effects of buflomedil on the responsiveness of canine vascular smooth muscleP M Vanhoutte, L L Aarhus, E Coen, et al.Acta Physiologica (Oxford, England)|November 11, 2010
Cross-talk between adipose tissue and vasculature: role of adiponectinF Y L Li, K K Y Cheng, K S L Lam, et al.The Annals of Thoracic Surgery|January 6, 1999
Nonpenetrating stapling: a valuable alternative for coronary anastomoses?G Lisi, L P Perrault, P Menasché, et al.Thrombosis and Haemostasis|September 1, 1995
Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptorV B Schini-Kerth, B Fisslthaler, T T Andersen, et al.British Journal of Pharmacology|July 6, 2000
Endothelial dysfunction in diabetesA S De Vriese, T J Verbeuren, J Van de Voorde, et al.British Journal of Pharmacology|March 22, 2000
Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary arteryG Edwards, C Thollon, M J Gardener, et al.Acta Pharmacologica Sinica|May 22, 2001
Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cellsI Deprez-Roy, F Coge, L Bertry, et al.European Journal of Pharmacology|October 24, 2001
The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidantsM Largeron, B Mesples, P Gressens, et al.Journal of Cardiovascular Pharmacology|January 1, 1980
Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylaseJ R Fozard, M Spedding, M G Palfreyman, et al.Journal of Cardiovascular Pharmacology|July 1, 1987
MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardiaM Spedding, G F DiFrancesco, A K Mir, et al.Pageof 64